Article
Anti-HIV-1 potency of the CRISPR/Cas9 system insufficient to fully inhibit viral replication.
Microbiology and immunology - 1 Jul 2016
Ueda Shuhei, Ebina Hirotaka, Kanemura Yuka, Misawa Naoko, Koyanagi Yoshio
Abstract excerpt
The range of genome-editing tools has recently been expanded. In particular, an RNA-guided genome-editing tool, the clustered regularly interspaced short palindromic repeat (CRISPR)-associated 9 (Cas9) system, has many applications for human diseases. In this study, guide RNA (gRNA) to target gag, pol and a long terminal repeat of HIV-1 was designed and used to generate gRNA-expressing lentiviral vectors. An...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
